High Doses of Melatonin Induce Seizure-like Cortical Activity: Electrophysiological and Behavioral Evidence
Open Access
- 5 May 2026
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (19) , 28560-28568
Abstract
Melatonin is widely used as a neurohormone and dietary supplement for sleep regulation and is generally regarded as safe in therapeutic doses. However, its neuropharmacological effects at supraphysiological concentrations have remained insufficiently characterized. In the present study, we investigated the behavioral and electrophysiological consequences of high-dose melatonin administration and examined the ability of classical anticonvulsant drugs to modulate its excitatory effects. Adult male Wistar rats received melatonin (100 mg/kg, ip), and behavioral responses were systematically recorded. Cortical activity was assessed by electrocorticography (ECoG) with spectral analysis of delta to γ frequency bands. Additional experimental groups received PTE, PBT, or DZP during the excitatory phase to evaluate pharmacological control of seizure-like activity. Melatonin induced a reproducible biphasic profile, characterized by an initial sedative and myorelaxant phase, followed by marked cortical hyperexcitability accompanied by tremors and clonic seizures. ECoG recordings revealed an increase in signal amplitude and power spectral density during the excitatory phase, particularly within β and γ oscillations, consistent with ictal-like activity. The administration of anticonvulsant agents significantly attenuated these electrophysiological alterations and reduced the behavioral manifestations of hyperexcitability. These results demonstrate that melatonin, at high doses, can shift from an inhibitory to a proexcitatory neuropharmacological profile, likely involving underlying mechanisms of disruption of central nervous system homeostasis. The study highlights a paradoxical action of melatonin on cortical excitability, raising concerns about the potential for intoxication in susceptible patients, such as children who are at risk.Keywords
Funding Information
- Universidade Federal do Pará
- Fundação Amazônia Paraense de Amparo à Pesquisa
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 46 references indexed in Scilit:
- Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disordersNaunyn-Schmiedeberg's Archives of Pharmacology, 2024
- Melatonin suppresses inflammation and blood‒brain barrier disruption in rats with vascular dementia possibly by activating the SIRT1/PGC-1α/PPARγ signaling pathwayInflammopharmacology, 2023
- Methods to Assess Melatonin Receptor-Mediated Phase-Shift and Re-entrainment of Rhythmic Behaviors in Mouse Models2022
- Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trialsJournal of Neurology, 2021
- Electrocorticographic description of the effects of anticonvulsant drugs used to treat lidocaine‐induced seizuresBrain and Behavior, 2020
- Role of Melatonin Receptors in Hyperthermia-Induced Acute Seizure Model of RatsJournal of Molecular Neuroscience, 2019
- Melatonin Alleviates Intracerebral Hemorrhage-Induced Secondary Brain Injury in Rats via Suppressing Apoptosis, Inflammation, Oxidative Stress, DNA Damage, and Mitochondria InjuryTranslational Stroke Research, 2017
- Optimal Dosages for Melatonin Supplementation Therapy in Older Adults: A Systematic Review of Current LiteratureDrugs & Aging, 2014
- Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative ProcessesNeurotoxicity Research, 2012
- Signaling in the suprachiasmatic nucleus: selectively responsive and integrativeCell and tissue research, 2002